Anticoagulant drugs antagonize coagulation and are used to prevent or cure (recurrent)
venous thromboembolism (VTE). Drugs to prevent clotting have been used for more than a …

Acute pulmonary embolism may occur rapidly and unpredictably and may be difficult to
diagnose. Treatment can reduce mortality, and appropriate primary prophylaxis is usually …

Background This article addresses the treatment of VTE disease. Methods We generated
strong (Grade 1) and weak (Grade 2) recommendations based on high-quality (Grade A) …

Background: Despite advances in hospital management in recent years, it is not clear
whether mortality after acute pulmonary embolism (PE) has decreased over time. Objectives …

Background Patients with cancer have a substantial risk of recurrent thrombosis despite the
use of oral anticoagulant therapy. We compared the efficacy of a low-molecular-weight …

Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep
vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention …

A small proportion of patients with deep vein thrombosis develop recurrent venous
thromboembolic complications or bleeding during anticoagulant treatment. These …

Background Chronic thromboembolic pulmonary hypertension (CTPH) is associated with
considerable morbidity and mortality. Its incidence after pulmonary embolism and …

This chapter about treatment for venous thromboembolic disease is part of the American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) …

Background: Estimates of the incidence of venous thrombosis (VT) vary, and data on
mortality are limited. Objectives: We estimated the incidence and mortality of a first VT event …